152 related articles for article (PubMed ID: 11518065)
1. In vitro effects of St. John's wort extract and hyperforin on 5 HT uptake and efflux in human blood platelets.
Uebelhack R; Franke L
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S146-7. PubMed ID: 11518065
[No Abstract] [Full Text] [Related]
2. Current St John's wort research from mode of action to clinical efficacy.
Müller WE
Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
[TBL] [Abstract][Full Text] [Related]
3. Hyperforin--antidepressant activity by a novel mechanism of action.
Müller WE; Singer A; Wonnemann M
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S98-102. PubMed ID: 11518085
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
Muruganandam AV; Bhattacharya SK; Ghosal S
Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
[TBL] [Abstract][Full Text] [Related]
5. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic actions of a dry methanolic extract of Hypericum perforatum and a hyperforin-rich extract on dopaminergic and serotonergic neurones in rat nucleus accumbens.
Rommelspacher H; Siemanowitz B; Mannel M
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S119-26. PubMed ID: 11518060
[TBL] [Abstract][Full Text] [Related]
7. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
Weber CC; Kressmann S; Fricker G; Müller WE
Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
[TBL] [Abstract][Full Text] [Related]
8. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
Butterweck V; Winterhoff H; Herkenham M
Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
[TBL] [Abstract][Full Text] [Related]
9. Effects of Hypericum perforatum (St. John's wort) on passive avoidance in the rat: evaluation of potential neurochemical mechanisms underlying its antidepressant activity.
Misane I; Ogren SO
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S89-97. PubMed ID: 11518084
[TBL] [Abstract][Full Text] [Related]
10. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
11. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.
Singer A; Wonnemann M; Müller WE
J Pharmacol Exp Ther; 1999 Sep; 290(3):1363-8. PubMed ID: 10454515
[TBL] [Abstract][Full Text] [Related]
12. Role of hyperforin in the pharmacological activities of St. John's Wort.
Zanoli P
CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort.
Wonnemann M; Singer A; Siebert B; Müller WE
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066
[TBL] [Abstract][Full Text] [Related]
14. Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex.
Simbrey K; Winterhoff H; Butterweck V
Life Sci; 2004 Jan; 74(8):1027-38. PubMed ID: 14672758
[TBL] [Abstract][Full Text] [Related]
15. Cellular neurobiology of hyperforin.
Bouron A
Phytother Res; 2024 Feb; 38(2):636-645. PubMed ID: 37963759
[TBL] [Abstract][Full Text] [Related]
16. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
[TBL] [Abstract][Full Text] [Related]
17. St. John's wort.
Lawvere S; Mahoney MC
Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
[TBL] [Abstract][Full Text] [Related]
18. St. John's wort: role of active compounds for its mechanism of action and efficacy.
Butterweck V; Schmidt M
Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
[TBL] [Abstract][Full Text] [Related]
19. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men.
Siepmann M; Krause S; Joraschky P; Mück-Weymann M; Kirch W
Br J Clin Pharmacol; 2002 Sep; 54(3):277-82. PubMed ID: 12236848
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
